Compare LVO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LVO | ABVC |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 26.7M |
| IPO Year | 2010 | 2009 |
| Metric | LVO | ABVC |
|---|---|---|
| Price | $2.39 | $1.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 52.5K | 36.9K |
| Earning Date | 11-16-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.57 | 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,144,000.00 | $509,589.00 |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $27.12 | $171.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.08 | $0.71 |
| 52 Week High | $7.19 | $3.06 |
| Indicator | LVO | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 48.47 |
| Support Level | $2.16 | $0.99 |
| Resistance Level | $5.83 | $1.14 |
| Average True Range (ATR) | 0.32 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 39.10 | 49.59 |
LiveOne Inc creator-first, music, entertainment and technology platform focused on delivering premium experiences and content world-wide through paid users and live and virtual events. It is in the acquisition, distribution and monetization of live music events, Internet radio, podcasting/vodcasting and music-related membership, streaming and video content. It provide services through a dedicated over-the-top application powered by Slacker (LiveOne App) called LiveOne. The company has three operating segments, PodcastOne, Slacker and Media Group. The company generates majority of revenue from PodcastOne. Its operations are based in the United States. It generate revenue through the sale of paid user services and advertising from its music offerings, from the licensing, advertising.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.